Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

0
Player Avatar tsperbeck (99.63) Submitted: 1/7/2011 1:16:02 PM : Underperform Start Price: $19.51 JAZZ Score: -130.77

Foolish10.

Featured Broker Partners


Advertisement